SLNO Operating Cash Flow (Statement)
Soleno Therapeutics Inc · Operating Cash Flow (Statement)
SLNO Operating Cash Flow (Statement)
Latest reported$105.71Mperiod ending
SLNO TTM Cash from Operations (-$885.22K → $105.71M)
TTM operating cash flow (statement)
High-resolution chart · PNG
SLNO operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| 105,708,000 | |
| 46,976,000 | |
| -25,719,000 | |
| -84,277,000 | |
| -89,320,000 | |
| -69,096,000 | |
| -51,419,000 | |
| -42,825,000 | |
| -30,740,000 | |
| -24,940,000 | |
| -23,769,000 | |
| -22,093,000 | |
| -21,147,000 | |
| -20,781,000 | |
| -22,501,000 | |
| -23,251,000 | |
| -26,644,000 | |
| -27,770,000 | |
| -27,774,000 | |
| -28,532,000 | |
| -27,053,000 | |
| -25,224,000 | |
| -23,433,000 | |
| -21,988,000 | |
| -19,347,000 | |
| -17,375,000 | |
| -16,035,000 | |
| -13,993,000 | |
| -12,850,000 | |
| -11,683,000 | |
| -10,678,958 | |
| -10,272,958 | |
| -10,286,958 | |
| -9,949,958 | |
| -9,905,980 | |
| -10,420,980 | |
| -11,696,980 | |
| -13,497,980 | |
| -14,188,330 | |
| -14,263,330 | |
| -12,474,330 | |
| -10,299,330 | |
| -8,477,362 | |
| -6,878,592 | |
| -5,784,003 | |
| -4,484,362 | |
| -3,650,218 | |
| -3,312,074 | |
| -3,479,472 | |
| -885,218 |